Literature DB >> 4326370

A study of the postoperative course after hepatic lobectomy.

J A Pinkerton, J L Sawyers, J H Foster.   

Abstract

Mesh:

Year:  1971        PMID: 4326370      PMCID: PMC1397544          DOI: 10.1097/00000658-197105000-00020

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  31 in total

1.  MANAGEMENT OF LIVER TRAUMA IN 259 CONSECUTIVE PATIENTS.

Authors:  R N MCCLELLAND; T SHIRES
Journal:  Ann Surg       Date:  1965-02       Impact factor: 12.969

2.  Mechanism of gastric hypersecretion in dogs with exclusion of bile or pancreatic juice from the small intestine.

Authors:  R B MENGUY
Journal:  Surg Forum       Date:  1962

3.  Metabolic function and regeneration of cirrhotic and non-cirrhotic livers after hepatic lobectomy in man.

Authors:  T Y Lin; C C Chen
Journal:  Ann Surg       Date:  1965-12       Impact factor: 12.969

4.  Biliary drainage in liver trauma.

Authors:  C E Lucas; R Lenaghan; A J Walt
Journal:  Surg Forum       Date:  1969

5.  Management of blunt trauma to the liver and hepatic veins.

Authors:  T Schrock; F W Blaisdell; C Mathewson
Journal:  Arch Surg       Date:  1968-05

6.  Massive hepatic resection in the treatment of severe liver trauma.

Authors:  F W Ackroyd; J Pollard; W V McDermott
Journal:  Am J Surg       Date:  1969-04       Impact factor: 2.565

7.  Enzyme and function changes after extensive liver resection in man.

Authors:  O Almersjö; S Bengmark; L O Hafström; R Olsson
Journal:  Ann Surg       Date:  1969-01       Impact factor: 12.969

8.  Technique of hepatic resection.

Authors:  J K Quattlebaum; J K Quattlebaum
Journal:  Surgery       Date:  1965-12       Impact factor: 3.982

9.  Critical decisions in liver trauma. Experience based on 604 cases.

Authors:  C E Lucas; A J Walt
Journal:  Arch Surg       Date:  1970-08

10.  Liver tumors in infants and children. Clinical and pathological analysis of 22 cases.

Authors:  H Nikaido; J Boggs; O Swenson
Journal:  Arch Surg       Date:  1970-08
View more
  9 in total

1.  Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection.

Authors:  T E Starzl; C W Putnam; C G Groth; J L Corman; J Taubman
Journal:  Am J Surg       Date:  1975-05       Impact factor: 2.565

2.  Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis.

Authors:  N Nagasue; H Yukaya; Y Ogawa; H Kohno; T Nakamura
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

3.  Upper gastrointestinal bleeding associated with biliary diversion after hepatic injury.

Authors:  J C Bowen; W H Fleming
Journal:  Ann Surg       Date:  1973-04       Impact factor: 12.969

4.  Long-term results of Roux-en-Y hepatocholangiojejunostomy.

Authors:  C E Lane; J L Sawyers; D H Riddle; H W Scott
Journal:  Ann Surg       Date:  1973-06       Impact factor: 12.969

5.  Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro.

Authors:  A Francavilla; C Panella; L Polimeno; A Di Leo; L Makowka; M Barone; A Amoruso; M Ingrosso; T E Starzl
Journal:  J Hepatol       Date:  1989-01       Impact factor: 25.083

6.  Laser surgery in exsanguinating liver injury.

Authors:  J P Fidler; R W Hoefer; T G Polanyi; H C Bredemeier; V E Siler; W A Altemeier
Journal:  Ann Surg       Date:  1975-01       Impact factor: 12.969

7.  Management of major hepatic resection in infants and children. Report of sixteen cases.

Authors:  Y Turmel; S Moussa; H Blanchard
Journal:  Can Anaesth Soc J       Date:  1973-07

8.  Acute upper gastrointestinal haemorrhage resulting in transient hepatic failure following liver resection.

Authors:  K Chao; F H G Bridgewater; G J Maddern
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

9.  The liver regenerative response elicited by antisecretory agents in partially hepatectomized rats: a comparison between omeprazole and famotidine.

Authors:  T Aono
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.